Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/34404
DC FieldValueLanguage
dc.contributor.authorHaslak, Fatihen_US
dc.contributor.authorOner, Nimeten_US
dc.contributor.authorElhani, Inèsen_US
dc.contributor.authorHinze, Tanjaen_US
dc.contributor.authorMamutova, Annaen_US
dc.contributor.authorBourguiba, Rimen_US
dc.contributor.authorKasap Cuceoglu, Muserrefen_US
dc.contributor.authorPateras, Konstantinosen_US
dc.contributor.authorAviel, Yonatan Butbulen_US
dc.contributor.authorDelplanque, Marionen_US
dc.contributor.authorCaorsi, Robertaen_US
dc.contributor.authorŠestan, Marioen_US
dc.contributor.authorBénard, Stéphanie Ducharmeen_US
dc.contributor.authorBrunner, Jürgenen_US
dc.contributor.authorEl Moussaoui, Majdoulineen_US
dc.contributor.authorKirijas, Merien_US
dc.contributor.authorConstantin, Tamasen_US
dc.contributor.authorArenas, Sonia Carriquíen_US
dc.contributor.authorKhellaf, Ghaliaen_US
dc.contributor.authorGuliyeva, Vafaen_US
dc.contributor.authorAssalia, Naieraen_US
dc.contributor.authorBackes, Stefanen_US
dc.contributor.authorSozeri, Betulen_US
dc.contributor.authorHofer, Michaëlen_US
dc.contributor.authorAyaz, Nurayen_US
dc.contributor.authorLachmann, Helenen_US
dc.contributor.authorWittkowski, Helmuten_US
dc.contributor.authorHentgen, Véroniqueen_US
dc.date.accessioned2025-12-01T13:05:44Z-
dc.date.available2025-12-01T13:05:44Z-
dc.date.issued2025-09-26-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/34404-
dc.description.abstractAlthough colchicine is the mainstay of familial Mediterranean fever (FMF) treatment, 5-10% of patients are considered to have colchicine resistance (CR). However, there is no globally agreed CR definition or indications for biological disease-modifying anti-rheumatic drugs (bDMARDs).en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Group Ltden_US
dc.relation.ispartofRMD openen_US
dc.subjectamyloidosisen_US
dc.subjectFamilial Mediterranean Feveren_US
dc.subjectBiological Therapyen_US
dc.subjectInterleukin 1 Receptor Antagonist Proteinen_US
dc.titleComparative analysis of global practices in the management of colchicine-resistant familial Mediterranean fever: a CliPS network analysisen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/rmdopen-2025-006097-
dc.identifier.urlhttps://syndication.highwire.org/content/doi/10.1136/rmdopen-2025-006097-
dc.identifier.volume11-
dc.identifier.issue3-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.